Based on the findings from this study, we conclude that SCT, α-thalassemia, G6PD mutations, and in-utero exposure to MSP-2 do not influence EBV susceptibility in infants from the malaria holoendemic region of Western Kenya. Here, G6PD is linked to thalassemia.